Complexa is a biopharmaceutical company focused on discovering and developing therapies for the treatment inflammatory and metabolic diseases. Initial focus is placed on acute and chronic kidney disease. Complexa's human network pharmacology discoveries have revealed new classes of drug candidates that are based on naturally-occurring activated fatty acids. Our lead compounds activate the body’s own protective mechanisms against inflammatory injury and metabolic stress.